{"summary":"Yanling is a technical leader with strong expertise in biologics\/medical device development and manufacturing. In the last 18 years, she has led R&D teams in the biotech sector across UK, USA and Australia. Yanling has a track record of bringing discovery projects through development to commercialisation with her versatile skills and experiences covering drug discovery and development, assay development, process development & CMC (Chemistry, Manufacturing and Controls), biomanufacturing (cGMP), clinical trials and regulatory. \n\nYanling was involved in the development of two commercial antibody therapeutic drugs. She has led the validation program for the FDA approval of a colorectal cancer diagnostic test InSure\u00ae ONE\u2122 and more recently played a critical role in the commercial implementation of the prostate cancer diagnostic test MiCheck\u00ae. Currently she is helping GlyTherix to develop their anti-glypican-1 antibodies as a targeted radiotherapy. \n\nYanling is a passionate individual and enjoys working in a dynamic environment which leverages her cross-disciplinary knowledge.  \n\nCore skills: CMC Program Management & Analytical Validation\n\u2022  Expertise in antibody engineering and product characterisation. \n\u2022  Expertise in analytical method development and validation. \n\u2022  Expertise in formulation development, stability testing and drug delivery. \n\u2022  Experienced in bioprocess development and cGMP manufacturing. \n\u2022  Experienced in radiopharmaceutical development.\n\u2022  Expertise in IVD test development and validation. \n\u2022  Experienced in point-of-care (POC) rapid test development. \n\u2022  Leadership in technology evaluation and tech transfer. \n\u2022  Accelerating programs from pre-clinical to clinical development. \n\u2022  Proficient in technical writing and QMS documentation.  \n\u2022  Conversant with regulatory requirements and guidelines (FDA, EMA, ICH, TGA and CLSI etc). \n\u2022  Effective project management and people management skills.","lastName":"Lu","objectUrn":"urn:li:member:11335328","geoRegion":"Greater Sydney Area","fullName":"Yanling Lu","firstName":"Yanling","currentPositions":[{"companyName":"GlyTherix  Ltd","description":"GlyTherix spun out from Minomic in Sep 2018 as an immuno-oncology company focusing on targeted radiotherapeutics for solid tumours. The company's core IPs are around human glypican-1 antigen and its targeting antibodies Miltuximab and Glytuzumab. GlyTherix is currently developing multiple radiopharmaceutical reagents for treatment of solid tumours. \n\u2022 I lead CMC project management and manufacturing strategy implementation. \n\u2022 I manage all projects with our contract development and manufacturing organisations (CDMOs). \n\u2022 I manage projects on antibody engineering and manufacturing, cell line development, process development, assay validation and product characterisation. \n\u2022 I manage bioconjugation programs to generate antibody drug conjugates (ADCs). \n\u2022 I involve in project management of the R&D projects and key R&D activities.\n\u2022 I regularly take part in the preparation of grant applications (e.g. CRC-P, BTB, MMI, ARC etc). \n\u2022 I was a key contributor in a $3M CRC-P grant awarded to Glytherix in Jul 2020 for a $12M project on \"Manufacturing consortium for cancer radioimmunotherapy\". This is currently a key program I project manage all the manufacturing activities for an upcoming Phase Ib trial.","title":"Head of CMC (Chemistry, Manufacturing and Controls) ","companyUrnResolutionResult":{"employeeCountRange":"2-10","headquarters":{"geographicArea":"New South Wales","country":"Australia","city":"Sydney","postalCode":"2113","line2":"Suite 2, ground floor","line1":"75 Talavera Rd"},"website":"https:\/\/glytherix.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/glytherix\/","industry":"Biotechnology"},"companyUrn":"urn:li:fs_salesCompany:19068052","tenureAtCompany":{"numYears":5,"numMonths":11},"startedOn":{"month":3,"year":2021}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAACs9qABQfBPZH5Z9oyRWgj1OS2JDvfh9iw,NAME_SEARCH,4oxD)","projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2006},"degree":"PhD","eduId":33272519,"schoolUrn":"urn:li:fs_salesSchool:7290","school":"urn:li:fs_salesSchool:7290","fieldsOfStudy":["Physical Biochemistry"],"schoolName":"University of Nottingham","startedOn":{"month":9,"year":2003}},{"endedOn":{"year":2003},"degree":"MSc","eduId":50089427,"schoolUrn":"urn:li:fs_salesSchool:7290","school":"urn:li:fs_salesSchool:7290","fieldsOfStudy":["Applied Biomolecular Technology"],"startedOn":{"year":2002}},{"endedOn":{"year":2002},"degree":"BSc","eduId":50089558,"schoolUrn":"urn:li:fs_salesSchool:442078","school":"urn:li:fs_salesSchool:442078","fieldsOfStudy":["Applied Chemistry"],"schoolName":"South China University of Technology","startedOn":{"year":1998}}],"skills":[{"numOfEndorsement":20,"name":"Biotechnology"},{"numOfEndorsement":18,"name":"Spectroscopy"},{"numOfEndorsement":15,"name":"NMR"},{"numOfEndorsement":9,"name":"HPLC"},{"numOfEndorsement":7,"name":"Protein Chemistry"},{"numOfEndorsement":6,"name":"Molecular Biology"},{"numOfEndorsement":4,"name":"Biochemistry"},{"numOfEndorsement":4,"name":"Protein Purification"},{"numOfEndorsement":2,"name":"Analytical method development"},{"numOfEndorsement":2,"name":"Scientific Writing"},{"numOfEndorsement":3,"name":"Technology Transfer"},{"numOfEndorsement":2,"name":"Formulation"},{"numOfEndorsement":2,"name":"GMP"},{"numOfEndorsement":2,"name":"FDA"},{"numOfEndorsement":4,"name":"Fluorescence"},{"numOfEndorsement":2,"name":"Structural Biology"},{"numOfEndorsement":2,"name":"Antibodies"},{"numOfEndorsement":1,"name":"X-ray scattering"},{"numOfEndorsement":1,"name":"Analytical ultracentrifigation"},{"numOfEndorsement":1,"name":"Bioprocessing and formulation development"},{"numOfEndorsement":1,"name":"Early-stage and pre-clinical drug development"}],"numOfConnections":1754,"patents":[],"headline":"Head of CMC | BioManufacturing | Biotech & Medtech | Antibody Therapeutics | Radiopharmaceuticals | Cancer Diagnostics | Product Characterisation & Validation","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/yanling-lu-9689673","organizations":[],"location":"Greater Sydney Area","publications":[],"positions":null,"posts":[{"createdAt":1714968660000,"insightId":"c103b5b5-11d6-4a80-8e4d-88bdd877cc50","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":6},{"type":"APPRECIATION","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7193100042809868288","threadUrn":"urn:li:ugcPost:7193100042809868288","reactionsCount":8,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193100042809868288","message":{"attributes":[],"text":"Recommending David to my network:"},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:jobSeeker:urn:li:member:4294359"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193098788012474368","message":{"attributes":[{"start":381,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:opentowork"}}}],"text":"Hey everyone! I\u2019m on the lookout for a new role and would really appreciate your support.\n\nI recently graduated as a GAICD and looking for director roles in companies that need to improve technology, cyber security, governance and processes at a board level. \n\nI am also open to CIO\/CTO roles.\n\nIf you hear of any exciting opportunities or are open to chatting, send me a message! #OpenToWork"},"entityUrn":"urn:li:ugcPost:7193098788012474368"},"entityUrn":"urn:li:ugcPost:7193100042809868288"}}},{"createdAt":1714968540000,"insightId":"3882da3b-0362-4dae-ab8d-2a837ecd8d73","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7193076184404930560,7193099648360665089)","threadUrn":"urn:li:activity:7193076184404930560","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":9,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:82358718"}}}],"text":"Congrats Paul McDonald and the team! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7193076184404930560"}}},{"createdAt":1712842320000,"insightId":"a851b2c7-8b32-4842-8d34-a8a1013e022d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7184082186751422464,7184181541923700736)","threadUrn":"urn:li:ugcPost:7184082186751422464","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks Brad. That's very kind\ud83d\ude0a"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184082186751422464"}}},{"createdAt":1712584260000,"insightId":"d7690104-7aa6-4965-9756-66d6972d90ec","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7183097438516252673,7183099160659730432)","threadUrn":"urn:li:activity:7183097438516252673","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congrats and happy birthday! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7183097438516252673"}}},{"createdAt":1712095440000,"insightId":"b1773d84-d459-488c-8cd5-e9e120138d26","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7181047807074607104,7181049002971348993)","threadUrn":"urn:li:activity:7181047807074607104","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":8,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:15384280"}}}],"text":"Welcome Colin Hayward!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7181047807074607104"}}},{"createdAt":1711618500000,"insightId":"e981cf8f-61b8-4198-aaca-8057ae9d101e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7179001285843591168,7179048373738483712)","threadUrn":"urn:li:activity:7179001285843591168","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Happy Easter Tim! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7179001285843591168"}}},{"createdAt":1711618440000,"insightId":"a33c5e6c-8b47-4ce0-974e-3986659cbf7d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7179005934050918400,7179048253634596864)","threadUrn":"urn:li:activity:7179005934050918400","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:282621586"}}}],"text":"Angela Jiehua Wu "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7179005934050918400"}}}]}